K. Sumegi

发表

Hodgkin Disease Therapy Induced Second Malignancy Susceptibility 6q21 Functional Variants in Roma and Hungarian Population Samples

B. Melegh, P. Kisfali, D. Várszegi, 2014, Pathology & Oncology Research.

High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature

B. Melegh, C. Sipeky, István Szabó, 2013, Molecular Biology Reports.

Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples

B. Melegh, E. Kóvesdi, B. Duga, 2017, Pathology & Oncology Research.

Activation of mitochondrial fusion provides a new treatment for mitochondria‐related diseases

F. Gallyas, J. Mandl, B. Sumegi, 2018, Biochemical pharmacology.

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids

B. Melegh, K. Hadzsiev, L. Járomi, 2014, Molecular Biology Reports.

Deletion of 4q28.3-31.23 in the background of multiple malformations with pulmonary hypertension

B. Melegh, P. Kisfali, K. Komlosi, 2014, Molecular Cytogenetics.

PARP Inhibition Attenuates Acute Kidney Allograft Rejection by Suppressing Cell Death Pathways and Activating PI-3K-Akt Cascade

F. Gallyas, B. Sumegi, P. Degrell, 2013, PloS one.

PARP inhibition protects mitochondria and reduces ROS production via PARP‐1‐ATF4‐MKP‐1‐MAPK retrograde pathway

F. Gallyas, B. Sumegi, B. Rácz, 2017, Free radical biology & medicine.

Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn’s disease and psoriasis

Z. Tulassay, L. Kemény, B. Melegh, 2013, Inflammation Research.

High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature

B. Melegh, C. Sipeky, István Szabó, 2013, Molecular Biology Reports.

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids

B. Melegh, K. Hadzsiev, D. Várszegi, 2014, Molecular Biology Reports.

Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene–gene interactions in inflammatory bowel disease

M. Szabó, Z. Tulassay, B. Melegh, 2012, International Journal of Immunogenetics.

Triglyceride Level Affecting Shared Susceptibility Genetic Variants in Type 2 Diabetes Mellitus

J. Bene, B. Melegh, P. Kisfali, 2013 .

Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

P. Sarlós, B. Melegh, D. Várszegi, 2014, World journal of orthopedics.

Functional Variants of Lipid Level Modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 Genes in Healthy Roma and Hungarian Populations

B. Melegh, L. Járomi, E. Kóvesdi, 2015, Pathology & Oncology Research.

Whole Exome Sequencing in a Series of Patients with a Clinical Diagnosis of Tuberous Sclerosis Not Confirmed by Targeted TSC1/TSC2 Sequencing

A. Kelemen, B. Melegh, V. Farkas, 2021, Genes.

Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

P. Sarlós, B. Melegh, E. Kóvesdi, 2014, World journal of gastroenterology.

BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species

F. Gallyas, B. Sumegi, A. Szabó, 2017, PloS one.